MedTrace Logo

Noninvasive Monitoring of Cerebral Blood Flow Autoregulation

NCT05170295 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 14

Last updated 2021-12-27

No results posted yet for this study

Summary

Rheoencephalography (REG) shows promise as a method for noninvasive neuromonitoring, because it reflects cerebrovascular reactivity. This protocol will study clinical and technical conditions required to use REG. Additionally, our goal is to study noninvasive peripheral bioimpedance pulse waveforms in order to substitute invasive SAP. A previous study demonstrated that REG can be used to detect spreading depolarization (SD), the early sign of brain metabolic disturbance. SD can be measured invasively with DC EEG amplifiers only. Our goal is to create an automatic notification function for REG monitoring indicating change of clinical conditions.

Conditions

  • Intracranial Pressure Increase
  • Cerebral Edema

Sponsors & Collaborators

  • Ochsner Health System

    lead OTHER

Principal Investigators

  • Louis Cannizzaro, MD · Ochsner

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-04-18
Primary Completion
2021-04-28
Completion
2021-04-28

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05170295 on ClinicalTrials.gov